EUVIMEDEUVIMED entdecken
Open Access

Perceived Availability of Lysergic Acid Diethylamide in the United States from 2015 to 2019

Brian S Barnett iD, Akhil Anand, Elizabeth N Dewey, Lee Hoffer, Jeremy Weleff iD

Psychedelic Medicine · 01.03.2026 · 4 (1) · 22-34

DOI: 10.1089/psymed.2024.0045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychedelic Medicine, online erschienen am 02.07.2025. Verfasst von Brian S Barnett und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Psychology, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

While data on perceived availability of lysergic acid diethylamide (LSD) [paLSD] are collected annually in the United States, detailed investigations of recent trends in paLSD have not been published. Therefore, we sought to explore this topic.

Method

Data were sourced from the 2015–2019 National Survey on Drug Use and Health (NSDUH) administrations. To identify factors associated with paLSD, exploratory multivariable models were constructed for respondents aged 12–17 (adolescents) and for respondents 18 and older (adults). Trends in paLSD among the whole sample and subpopulations were investigated.

Results

Among 281,464 respondents, 13.1% reported LSD was “fairly” or “very easy” to obtain. In adults, higher paLSD was associated with identifying as bisexual, experiencing past year serious psychological distress, higher education, and lifetime use of alcohol, marijuana, or hallucinogens. Negative associations included older age, identifying as Asian or Black, and lifetime stimulant use. In adolescents, unique associations included lower paLSD among males and Hispanic individuals, and higher paLSD with lifetime stimulant use. A small but statistically significant increase in paLSD was observed over the study period, especially among subgroups such as males, bisexual respondents, respondents reporting past year serious psychological distress, and those with hallucinogen use disorder or lower perceived risk of trying LSD. Identifying as Black was associated with a decreasing trend.

Conclusions

While LSD remains widely perceived as difficult to obtain, paLSD is increasing among several subpopulations. Monitoring these trends and identifying associated characteristics may inform targeted harm reduction efforts and public health messaging.

Schlagwörter

Stichwörter der Autor:innen

LSDperceived availabilitypsychedelicssubstance usesurvey

Autor:innen und Institutionen

  • Department of Psychiatry and Psychology, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, EC-10 Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA.
  • Center for Populations Health Research, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Medical Anthropology and Psychiatry, Case Western Reserve University, Cleveland, Ohio, USA.
  • Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.

ORCID-Profile: Brian S Barnett, Jeremy Weleff

Zitieren

APA

Barnett, B. S., Anand, A., Dewey, E. N., Hoffer, L., & Weleff, J. (2026). Perceived Availability of Lysergic Acid Diethylamide in the United States from 2015 to 2019. Psychedelic Medicine, 4(1), 22-34. https://doi.org/10.1089/psymed.2024.0045

Vancouver

Barnett BS, Anand A, Dewey EN, Hoffer L, Weleff J. Perceived Availability of Lysergic Acid Diethylamide in the United States from 2015 to 2019. Psychedelic Medicine. 2026;4(1):22-34. doi:10.1089/psymed.2024.0045

BibTeX
@article{Barnett2026,
  author = {Barnett, Brian S and Anand, Akhil and Dewey, Elizabeth N and Hoffer, Lee and Weleff, Jeremy},
  title = {Perceived Availability of Lysergic Acid Diethylamide in the United States from 2015 to 2019},
  journal = {Psychedelic Medicine},
  year = {2026},
  volume = {4},
  number = {1},
  pages = {22--34},
  doi = {10.1089/psymed.2024.0045}
}
Kostenlos starten →